Identification and mechanism of action of the acylguanidine MRT-83, a novel potent Smoothened antagonist. 2011

Hermine Roudaut, and Elisabeth Traiffort, and Tatiana Gorojankina, and Ludwig Vincent, and Helene Faure, and Angele Schoenfelder, and Andre Mann, and Fabrizio Manetti, and Antonio Solinas, and Maurizio Taddei, and Martial Ruat
Laboratoire de Neurobiologie et Développement, Institut de Neurobiologie Alfred Fessard IFR2118, Centre National de la Recherche Scientifique, UPR-3294, Gif-sur-Yvette, France.

There is a clear need to develop novel pharmacological tools to improve our understanding of Smoothened (Smo) function in normal and pathological states. Here, we report the discovery, the mechanism of action, and the in vivo activity of N-(2-methyl-5-(3-(3,4,5-trimethoxybenzoyl)guanidino)phenyl)biphenyl-4-carboxamide (MRT-83), a novel potent antagonist of Smo that belongs to the acylguanidine family of molecules. MRT-83 fits to a proposed pharmacophoric model for Smo antagonists with three hydrogen bond acceptor groups and three hydrophobic regions. MRT-83 blocks Hedgehog (Hh) signaling in various assays with an IC50 in the nanomolar range, showing greater potency than the reference Smo antagonist cyclopamine. MRT-83 inhibits Bodipy-cyclopamine binding to human and mouse Smo but does not modify Wnt signaling in human embryonic kidney 293 transiently transfected with a Tcf/Lef-dependent Firefly luciferase reporter together with a Renilla reniformis luciferase control reporter. MRT-83 abrogates the agonist-induced trafficking of endogenous mouse or human Smo to the primary cilium of C3H10T1/2 or NT2 cells that derive from a pluripotent testicular carcinoma. Stereotaxic injection into the lateral ventricle of adult mice of MRT-83 but not of a structurally related compound inactive at Smo abolished up-regulation of Patched transcription induced by Sonic Hedgehog in the neighboring subventricular zone. These data demonstrate that MRT-83 efficiently antagonizes Hh signaling in vivo. All together, these molecular, functional and biochemical studies provide evidence that MRT-83 interacts with Smo. Thus, this novel Smo antagonist will be useful for manipulating Hh signaling and may help develop new therapies against Hh-pathway related diseases.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002531 Cerebellum The part of brain that lies behind the BRAIN STEM in the posterior base of skull (CRANIAL FOSSA, POSTERIOR). It is also known as the "little brain" with convolutions similar to those of CEREBRAL CORTEX, inner white matter, and deep cerebellar nuclei. Its function is to coordinate voluntary movements, maintain balance, and learn motor skills. Cerebella,Corpus Cerebelli,Parencephalon,Cerebellums,Parencephalons
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072079 Patched Receptors A family of 12-pass transmembrane proteins originally identified in Drosophila that are receptors for HEDGEHOG PROTEINS. They have important roles in regulating CELL PROLIFERATION; CELL DIFFERENTIAION; and BODY PATTERNING and may also function as TUMOR SUPPRESSOR PROTEINS. Patched Protein,Patched Receptor,Patched Sonic Hedgehog Receptors,Receptor, Patched,Receptors, Patched
D000072086 Smoothened Receptor A frizzled-like, G-protein-coupled receptor that associates with PATCHED RECEPTORS to transduce signals from HEDGEHOG PROTEINS and initiate hedgehog signaling to ZINC FINGER PROTEIN GLI1. It may normally inhibit signaling in the absence of SONIC HEDGEHOG PROTEIN binding to PATCHED RECEPTOR-1. Smoothened Protein,Smoothened Receptors,Receptor, Smoothened,Receptors, Smoothened
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Hermine Roudaut, and Elisabeth Traiffort, and Tatiana Gorojankina, and Ludwig Vincent, and Helene Faure, and Angele Schoenfelder, and Andre Mann, and Fabrizio Manetti, and Antonio Solinas, and Maurizio Taddei, and Martial Ruat
December 2018, Cells,
Hermine Roudaut, and Elisabeth Traiffort, and Tatiana Gorojankina, and Ludwig Vincent, and Helene Faure, and Angele Schoenfelder, and Andre Mann, and Fabrizio Manetti, and Antonio Solinas, and Maurizio Taddei, and Martial Ruat
March 2021, Cell & bioscience,
Hermine Roudaut, and Elisabeth Traiffort, and Tatiana Gorojankina, and Ludwig Vincent, and Helene Faure, and Angele Schoenfelder, and Andre Mann, and Fabrizio Manetti, and Antonio Solinas, and Maurizio Taddei, and Martial Ruat
November 2012, Bioorganic & medicinal chemistry,
Hermine Roudaut, and Elisabeth Traiffort, and Tatiana Gorojankina, and Ludwig Vincent, and Helene Faure, and Angele Schoenfelder, and Andre Mann, and Fabrizio Manetti, and Antonio Solinas, and Maurizio Taddei, and Martial Ruat
June 2010, ACS medicinal chemistry letters,
Hermine Roudaut, and Elisabeth Traiffort, and Tatiana Gorojankina, and Ludwig Vincent, and Helene Faure, and Angele Schoenfelder, and Andre Mann, and Fabrizio Manetti, and Antonio Solinas, and Maurizio Taddei, and Martial Ruat
November 2022, International journal of molecular sciences,
Hermine Roudaut, and Elisabeth Traiffort, and Tatiana Gorojankina, and Ludwig Vincent, and Helene Faure, and Angele Schoenfelder, and Andre Mann, and Fabrizio Manetti, and Antonio Solinas, and Maurizio Taddei, and Martial Ruat
January 2016, PloS one,
Hermine Roudaut, and Elisabeth Traiffort, and Tatiana Gorojankina, and Ludwig Vincent, and Helene Faure, and Angele Schoenfelder, and Andre Mann, and Fabrizio Manetti, and Antonio Solinas, and Maurizio Taddei, and Martial Ruat
September 2001, Current drug targets,
Hermine Roudaut, and Elisabeth Traiffort, and Tatiana Gorojankina, and Ludwig Vincent, and Helene Faure, and Angele Schoenfelder, and Andre Mann, and Fabrizio Manetti, and Antonio Solinas, and Maurizio Taddei, and Martial Ruat
April 2012, British journal of pharmacology,
Hermine Roudaut, and Elisabeth Traiffort, and Tatiana Gorojankina, and Ludwig Vincent, and Helene Faure, and Angele Schoenfelder, and Andre Mann, and Fabrizio Manetti, and Antonio Solinas, and Maurizio Taddei, and Martial Ruat
March 2001, Biochemical and biophysical research communications,
Hermine Roudaut, and Elisabeth Traiffort, and Tatiana Gorojankina, and Ludwig Vincent, and Helene Faure, and Angele Schoenfelder, and Andre Mann, and Fabrizio Manetti, and Antonio Solinas, and Maurizio Taddei, and Martial Ruat
March 2004, British journal of cancer,
Copied contents to your clipboard!